(Q39856063)

15 September 2017

Susceptibility of zygomycetes to amphotericin B, miconazole, and ketoconazole (English)

1 reference

15 September 2017

1 reference

Eng RH

1

1 reference

15 September 2017

Person A

2

1 reference

15 September 2017

Mangura C

3

1 reference

15 September 2017

Chmel H

4

1 reference

15 September 2017

Corrado M

5

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 November 1981

1 reference

Antimicrobial Agents and Chemotherapy

15 September 2017

1 reference

15 September 2017

20

1 reference

15 September 2017

5

1 reference

15 September 2017

688-690

1 reference

Mechanism of action of antifungal drugs, with special reference to the imidazole derivatives.

15 September 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181775

Rhinocerebral phycomycosis in association with diabetic ketoacidosis. Report of two cases and a review of clinical and experimental experience with amphotericin B therapy

22 September 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181775

The activity of ketoconazole in mixed cultures of fungi and human fibroblasts

22 September 2017

1 reference

12 December 2020

1 reference

12 December 2020

In vitro activity of amphotericin B on strains of Mucoraceae pathogenic to man

1 reference

12 December 2020

An Evaluation of Two Years of Clinical Experience with Ketoconazole

1 reference

12 December 2020

Susceptibility of Zygomycetes to human serum

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.20.5.688

1 reference

15 September 2017

1 reference

15 September 2017

PubMed publication ID

6275783

1 reference